🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients who had clinical benefit following a single infusion of CP-870, 89...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2005-07
Trial ID
NCT02157831
Treatments Being Tested
This open-label, two-part study is designed to assess the safety, PK, PD, a...
Status
Completed
Location
Cedars Sinai Medical Center
Start Date
2016-01-25
Trial ID
NCT02665416
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as tremelimumab and CD40 agonist mon...
Status
Completed
Location
Abramson Cancer Center of The University of Pennsylvania
Start Date
2010-02
Trial ID
NCT01103635
Treatments Being Tested
This is an open-label, multicenter study designed to assess the safety, pha...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2016-05-09
Trial ID
NCT02760797
Treatments Being Tested
This is a pilot study to evaluate the role of the addition of CP870, 893 to...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2012-04
Trial ID
NCT01456585
Treatments Being Tested
The purpose of this study is to determine what side effects CP 870,893 may ...
Status
Completed
Location
H. Lee Moffitt Cancer Center & Research Institute
Start Date
2009-10
Trial ID
NCT01008527
Treatments Being Tested
This is a dose-finding study; therefore, there is no hypothesis testing...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2007-11
Trial ID
NCT00607048
Treatments Being Tested
This is an open-label, multicenter study designed to assess the safety, pha...
Status
Completed
Location
University of Pennsylvania
Start Date
2014-12-12
Trial ID
NCT02304393
Treatments Being Tested
A phase Ib/II, open-label, multicenter, randomized study designed to assess...
Status
Terminated
Location
City of Hope Comprehensive Cancer Center
Start Date
2018-09-27
Trial ID
NCT03555149
Treatments Being Tested
This is a multicenter, open, dose escalation phase Ib trial of intratumoral...
Status
Terminated
Location
APHP - Hôpital Henri Mondor
Start Date
2019-07-04
Trial ID
NCT03892525
Treatments Being Tested